Core--Cyclotron &radiochemistry facility

$99,689P50FY2005CANIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications & trials

Paper 37823267 Paper 33741600 Paper 32357967 Paper 29910881 Paper 29167603 Paper 28905308 Paper 28890550 Paper 28662441 Paper 28202506 Paper 27612034 Paper 27393689 Paper 27273450 Paper 27035974 Paper 26759318 Paper 26712011 Paper 26621741 Paper 26573799 Paper 26491162 Paper 26478693 Paper 26102222 Paper 25952734 Paper 25939769 Paper 25856776 Paper 25822024 Paper 25817443 Paper 25787767 Paper 25645078 Paper 25500825 Paper 25467460 Paper 25398666 Paper 25162396 Paper 25063587 Paper 24994929 Paper 24988319 Paper 24982199 Paper 24971026 Paper 24812408 Paper 24687922 Paper 24685748 Paper 24634374 Paper 24604590 Paper 24567448 Paper 24469308 Paper 24419380 Paper 24345644 Paper 24305722 Paper 24268915 Paper 24247719 Paper 23947754 Paper 23874970 Paper 23850620 Paper 23841937 Paper 23628700 Paper 23561594 Paper 23519018 Paper 23490445 Paper 23481324 Paper 23440422 Paper 23416162 Paper 23322346 Paper 23271478 Paper 23148236 Paper 23054556 Paper 22784710 Paper 22763855 Paper 22693252 Paper 22576205 Paper 22570488 Paper 22392499 Paper 22338012 Paper 22302964 Paper 22159180 Paper 22123951 Paper 22074768 Paper 22045706 Paper 22020872 Paper 21868765 Paper 21850545 Paper 21841971 Paper 21646475 Paper 21630083 Paper 21596747 Paper 21498533 Paper 21496447 Paper 21492784 Paper 21142653 Paper 21127859 Paper 20930933 Paper 20842061 Paper 20802234 Paper 20660389 Paper 20640185 Paper 20639890 Paper 20639814 Paper 20628903 Paper 20624956 Paper 20578830 Paper 20554721 Paper 20527045 Paper 20495880

Abstract

D.I.I. Introduction: The Cyclotron and Radiochemistry facility is a Specialized Resource component of both the UCLA-ICMIC and the UCLA Department of Energy Molecular Medicine program. Our history with the DoE program predates the initiation of the NCI ICMIC, extending back for over three decades. The prime objective of the Cyclotron and Radiochemistry Specialized Resource is to foster all radiopharmaceutical needs of UCLA-ICMIC and UCLA-DoE investigators, and to serve other UCLA research projects that complement these research programs.

View original record on NIH RePORTER →